Table 3. Characteristics of the IL-6-neutralizing sIL-6R-sgp130 buffer system in CAD patients stratified by number of stenotic vessels.
| Characteristic | 1-vessel (n=89) | 2-vessel (n=28) | 3-vessel (n=38) | P value |
|---|---|---|---|---|
| IL-6 (pg/mL) | 5.84 (4.78–10.61) | 6.61 (5.47–9.33) | 6.29 (5.00–11.00) | 0.753 |
| sIL-6Rα (ng/mL) | 17.85 (15.47–22.35) | 18.08 (14.84–24.33) | 18.38 (14.73–22.14) | 0.937 |
| sgp130 (ng/mL) | 99.53 (85.25–121.14) | 108.80 (92.61–129.24) | 106.39 (94.60–121.19) | 0.432 |
| B/T ratio | 1.55 (1.50–1.62) | 1.54 (1.47–1.62) | 1.55 (1.47–1.61) | 0.852 |
Data were presented as median (interquartile range, IQR) and differences among groups were compared using Mann-Whitney U test. CAD, coronary artery disease; IL-6, interleukin-6; sIL-6Rα, soluble interleukin-6 receptor α; sgp130, soluble glycoprotein 130; B/T ratio, binary/ternary complex ratio.